Craig Hallum downgraded Cardlytics from Buy to Hold
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 10/11/2024 | $4.00 | In-line | Evercore ISI |
| 8/16/2024 | $5.00 | Outperform → Market Perform | Northland Capital |
| 8/15/2024 | $4.00 → $3.50 | Neutral → Underperform | BofA Securities |
| 8/8/2024 | Buy → Hold | Craig Hallum | |
| 8/8/2024 | Buy → Hold | Needham | |
| 8/8/2024 | $18.00 → $5.00 | Buy → Hold | Lake Street |
| 6/20/2024 | $11.00 | Neutral | BofA Securities |
| 6/18/2024 | $14.00 | Outperform | Northland Capital |
4 - Cardlytics, Inc. (0001666071) (Issuer)
4 - Cardlytics, Inc. (0001666071) (Issuer)
4 - Cardlytics, Inc. (0001666071) (Issuer)
8-K - Cardlytics, Inc. (0001666071) (Filer)
10-Q - Cardlytics, Inc. (0001666071) (Filer)
8-K - Cardlytics, Inc. (0001666071) (Filer)
Evercore ISI initiated coverage of Cardlytics with a rating of In-line and set a new price target of $4.00
Northland Capital downgraded Cardlytics from Outperform to Market Perform and set a new price target of $5.00
BofA Securities downgraded Cardlytics from Neutral to Underperform and set a new price target of $3.50 from $4.00 previously
Cardlytics, Inc. (NASDAQ:CDLX) today announced that its financial results for the third quarter ending September 30, 2025 will be released on November 5, 2025, after market close. Conference Call Details: When: November 5, 2025 at 5:00 pm Eastern time / 2:00 pm Pacific time Webcast: Attendees may access the live audio webcast on the Cardlytics Investor Relations website at ir.cardlytics.com, or by registering at this link. Following the call, a replay will be available on the website. Dial-in: Call participants may dial +1 800-549-8228 and use Conference ID: 18219. About Cardlytics Cardlytics (NASDAQ:CDLX) is a commerce media platform, powered by our publishers' first-party
Cardlytics Inc. (NASDAQ:CDLX) today announced an enterprise-wide cost savings initiative aimed at optimizing its cost structure and aligning resources with its most critical business priorities. As part of this effort, Cardlytics reduced its workforce by approximately 120 full-time employees and contractors, representing about 30% of its total workforce. Cardlytics expects to incur $2.3 million in severance and related expenses in connection with this reduction, most of which will be recognized in the fourth quarter of 2025. "This was a very difficult decision, but one that is necessary to protect the long-term stability of our business," said Amit Gupta, Chief Executive Officer of Cardly
Cardlytics Inc. (NASDAQ:CDLX) today announced the full and timely repayment of the remaining $46.1 million aggregate principal amount of its 1.00% convertible senior notes due on September 15, 2025. Following this repayment, Cardlytics now has $172.5 million aggregate principal amount outstanding of its 4.25% convertible senior notes due in 2029 and $50 million drawn on its line of credit. Cardlytics' cash and cash equivalents as of August 31, 2025 was $92.7 million and the Company is in compliance with all financial covenants related to its line of credit. "In our current environment, disciplined cash management remains a top priority for us. We are evaluating all options to optimize our
4 - Cardlytics, Inc. (0001666071) (Issuer)
4 - Cardlytics, Inc. (0001666071) (Issuer)
4 - Cardlytics, Inc. (0001666071) (Issuer)
Co-founder and CEO of Cardlytics, Greenlight CMO to Provide Decades of Operational and Marketing Expertise to Portfolio Companies as Firm Enters 25th Year of Fintech Investing ATLANTA, April 30, 2025 /PRNewswire/ -- TTV Capital, an early-stage fintech venture capital firm, today announced that Lynne Laube and Rachel Hamilton have joined as venture partners. In these roles, Lynne and Rachel will provide strategic counsel to TTV Capital's portfolio companies based on their decades of experience scaling early-stage fintech companies. Today's news arrives as TTV Capital marks its 25th year of investing from its home base in Atlanta, the center of the fintech ecosystem. "We started investing in
SUNNYVALE, Calif., Oct. 29, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (NASDAQ:ME) (the "Company" or "23andMe"), a leading human genetics and preventive health company, today announced the appointments of Andre Fernandez, Jim Frankola, and Mark Jensen, three accomplished and experienced executives, as independent members of the Company's Board of Directors (the "Board"), effective on October 28, 2024. Each of Mr. Fernandez, Mr. Frankola, and Mr. Jensen have been appointed to serve as members of the Board's Audit Committee and Compensation Committee, with Mr. Fernandez serving as the Chair of the Audit Committee and Mr. Jensen serving as the Chair of the Compensation Committee. In additio
ATLANTA, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Cardlytics, Inc. (NASDAQ:CDLX), a digital advertising platform, today announced that the Board of Directors has appointed Amit Gupta, Chief Operating Officer and General Manager of Bridg, as its next Chief Executive Officer of Cardlytics, effective August 16, 2024. He will also join the Cardlytics Board of Directors on that date. Mr. Gupta will succeed Karim Temsamani, who is stepping down as Chief Executive Officer and from the Board of Directors to pursue another professional opportunity. "Amit is the right person to lead Cardlytics in its next stage of growth," said Jack Klinck, Chair of the Cardlytics Board. "For the last year and a half, Ami
SC 13D/A - Cardlytics, Inc. (0001666071) (Subject)
SC 13D/A - Cardlytics, Inc. (0001666071) (Subject)
SC 13D/A - Cardlytics, Inc. (0001666071) (Subject)
Cardlytics, Inc. (NASDAQ:CDLX) today announced that its financial results for the third quarter ending September 30, 2025 will be released on November 5, 2025, after market close. Conference Call Details: When: November 5, 2025 at 5:00 pm Eastern time / 2:00 pm Pacific time Webcast: Attendees may access the live audio webcast on the Cardlytics Investor Relations website at ir.cardlytics.com, or by registering at this link. Following the call, a replay will be available on the website. Dial-in: Call participants may dial +1 800-549-8228 and use Conference ID: 18219. About Cardlytics Cardlytics (NASDAQ:CDLX) is a commerce media platform, powered by our publishers' first-party
Cardlytics, Inc. (NASDAQ:CDLX), a commerce media platform, today announced financial results for the second quarter ended June 30, 2025. "Building on the progress we've made over the past year, we are navigating headwinds by doubling down on our diversification efforts and reinforcing our unique network capabilities," said Amit Gupta, CEO of Cardlytics. "We believe our strategic shifts will position us for long-term profitable growth and enable us to deliver on the promise to our stakeholders." Second Quarter 2025 Financial Results Revenue was $63.2 million, a decrease of 9% year-over-year compared to $69.6 million in the second quarter of 2024. Billings, a non-GAAP metric, was $1
Cardlytics, Inc. (NASDAQ:CDLX) today announced that its financial results for the second quarter ending June 30, 2025 will be released on August 6, 2025, after market close. Conference Call Details: When: August 6, 2025 at 5:00 pm Eastern time / 2:00 pm Pacific time Webcast: Attendees may access the live audio webcast on the Cardlytics Investor Relations website at ir.cardlytics.com, or by registering at this link. Following the call, a replay will be available on the website. Dial-in: Call participants may dial +1 800-549-8228 and use Conference ID: 14299. About Cardlytics Cardlytics (NASDAQ:CDLX) is a commerce media platform, powered by our publishers' first-party purchase